Pipeline
Our pipeline programs include both novel isoform-selective small molecule kinase inhibitors of the PI3K/Akt/mTOR signaling network.
858.768.6500 phone
858.558.5988 fax
Intellikine is a clinical-stage company discovering and developing small molecule drugs that target signal transduction networks for the treatment of cancer and other diseases. Learn More
Our pipeline programs include both novel isoform-selective small molecule kinase inhibitors of the PI3K/Akt/mTOR signaling network.